AMANDA SMITH: Open Payments
NPI 1205503927 · CLAYTON, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$519 in 36 payments from 10 companies in 2025. Trend: 2023 $468 · 2024 $1,111 · 2025 $519
Food & beverage: $519
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 15 | $137 |
| Novo Nordisk Inc | 6 | $111 |
| AstraZeneca Pharmaceuticals LP | 3 | $57 |
| SHIELD THERAPEUTICS INC | 2 | $47 |
| Lilly USA, LLC | 3 | $47 |
| Corium, LLC | 3 | $35 |
| Astellas Pharma US Inc | 1 | $29 |
| GlaxoSmithKline, LLC. | 1 | $20 |
| PFIZER INC. | 1 | $19 |
| Exact Sciences Corporation | 1 | $17 |
Products named: Wegovy, VRAYLAR, UBRELVY, ACCRUFER, MOUNJARO, AIRSUPRA, Azstarys, Veozah.
Industry payments across GA — which companies pay providers there.
